Real-time enrollment status for this exudative macular degeneration clinical trial
Current Status
Recruiting
Checked: July 20, 2026 at 4:39 AM UTC
| NCT Number | NCT04504123 |
| Recruiting Status | Recruiting |
| Condition | Exudative Macular Degeneration |
| Phase | PHASE2 |
| Target Enrollment | 50 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Iowa |
| Last Updated on CT.gov | April 2, 2026 (Apr 2, 2026) |
As of July 20, 2026: Clinical trial NCT04504123 is currently recruiting participants. This phase2 study for exudative macular degeneration is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Iowa. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04504123 is actively recruiting participants as of July 20, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04504123 was last updated Apr 2, 2026 (April 2, 2026). HelloStudys verifies this status automatically.